易方达全球医药行业混合发起式(QDII)A(人民币)(008284)财务指标
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 本期已实现收益 |
-391,393,239.38 |
-166,224,472.18 |
-102,799,875.94 |
-58,950,395.84 |
| 本期利润 |
-159,968,674.41 |
-186,357,716.34 |
-234,805,111.81 |
-250,266,483.86 |
| 加权平均基金份额本期利润 |
-0.13 |
-0.14 |
-0.18 |
-0.20 |
| 本期加权平均净值利润率(%) |
-17.06 |
-19.53 |
-19.80 |
-20.28 |
| 本期基金份额净值增长率(%) |
-14.92 |
-16.65 |
-17.25 |
-18.37 |
| 期末可供分配利润 |
-322,120,008.36 |
-379,952,328.75 |
-205,070,851.71 |
-215,511,961.46 |
| 期末可供分配基金份额利润 |
-0.28 |
-0.29 |
-0.15 |
-0.16 |
| 期末基金资产净值 |
829,072,888.99 |
910,636,411.50 |
1,131,222,245.21 |
1,091,251,406.81 |
| 期末基金份额净值 |
0.72 |
0.71 |
0.85 |
0.84 |
| 基金份额累计净值增长率(%) |
-27.98 |
-29.44 |
-15.35 |
-16.49 |
微信公众号
证券之星APP
基本资料
